text,labels
Normal-weight subjects showed significant blood oxygen level-dependent responses in the ventromedial prefrontal cortex ( vmPFC ) to food aromas compared with responses induced by the odor of an inedible object .,3
Female : 35.6 % .,3
"PrEP is efficacious for HIV-1 prevention among women using DMPA and men whose partners use DMPA , suggesting PrEP could mitigate the potential increased HIV-1 acquisition and transmission risks that have been associated with DMPA use .",4
"The SSM 30 g may be an effective , noninvasive alternative to health care provider-administered intravenous , intramuscular , or oral opioids for the management of moderate-to-severe acute pain .",4
Normal-weight ğšœğšğš‹ğš“ğšğšŒğšğšœ ğ“¼ğ“±ğ“¸ğ”€ğ“®ğ“­ significant blood oxygen level-ğ—±ğ—²ğ—½ğ—²ğ—»ğ—±ğ—²ğ—»ğ˜ ğš›ğšğšœğš™ğš˜ğš—ğšœğšğšœ in the ventromedial prefrontal cortex (vmPFC) ğ•¥ğ•  food aromas compared with responses ğ’Šğ’ğ’…ğ’–ğ’„ğ’†ğ’… by the odor ğ”¬ğ”£ ğšŠğš— inedible ğ—¼ğ—¯ğ—·ğ—²ğ—°ğ˜.,3
ğ˜•ğ˜°ğ˜³ğ˜®ğ˜¢ğ˜­-weight subjects sÍhÍoÍwÍeÍdÍ sÌ²iÌ²gÌ²nÌ²iÌ²fÌ²iÌ²cÌ²aÌ²nÌ²tÌ² blood oxygen level-dependent responses ğ—¶ğ—» the ğ˜·ğ˜¦ğ˜¯ğ˜µğ˜³ğ˜°ğ˜®ğ˜¦ğ˜¥ğ˜ªğ˜¢ğ˜­ prefrontal ğ•”ğ• ğ•£ğ•¥ğ•–ğ•© (vmPFC) ğ”±ğ”¬ food aÌ²rÌ²oÌ²mÌ²aÌ²sÌ² compared with ğ«ğğ¬ğ©ğ¨ğ§ğ¬ğğ¬ induced by ğ­ğ¡ğ odor of an inedible object.,3
Normal-weight subjects showed sÌ³iÌ³gÌ³nÌ³iÌ³fÌ³iÌ³cÌ³aÌ³nÌ³tÌ³ blood oxygen level-ğ’¹ğ‘’ğ“…ğ‘’ğ“ƒğ’¹ğ‘’ğ“ƒğ“‰ rÌ²eÌ²sÌ²pÌ²oÌ²nÌ²sÌ²eÌ²sÌ² ğ•šğ•Ÿ ğ˜µğ˜©ğ˜¦ ventromedial prefrontal cortex (vmPFC) to fÌ²oÌ²oÌ²dÌ² aromas compared with responses induced bÌ½Í“yÌ½Í“ the odor of ğ”ğ”« ğ—¶ğ—»ğ—²ğ—±ğ—¶ğ—¯ğ—¹ğ—² object.,3
Normal-weight subjects showed significant bÌ¶lÌ¶oÌ¶oÌ¶dÌ¶ ğ’ğ’™ğ’šğ’ˆğ’†ğ’ level-dependent responses in the ventromedial ğš™ğš›ğšğšğš›ğš˜ğš—ğšğšŠğš• cÌ³oÌ³rÌ³tÌ³eÌ³xÌ³ (Ì¾ vmPFC) ğ™©ğ™¤ food aromas compared with responses ğ’Šğ’ğ’…ğ’–ğ’„ğ’†ğ’… bÌ²yÌ² the odor ğ™¤ğ™› an inedible object.,3
Normal-wÌ´eÌ´iÌ´gÌ´hÌ´tÌ´ subjects ğ’”ğ’‰ğ’ğ’˜ğ’†ğ’… significant blood oÌ³xÌ³yÌ³gÌ³eÌ³nÌ³ level-dependent responses iÌ´nÌ´ ğ“½ğ“±ğ“® ventromedial prefrontal cortex (vmPFC) to food ğšŠğš›ğš˜ğš–ğšŠğšœ compared with responses iÌ·nÌ·dÌ·uÌ·cÌ·eÌ·dÌ· bÌ³yÌ³ the á´á´…á´Ê€ of an inedible object.,3
Normal -Ì· wÌ½Í“eÌ½Í“iÌ½Í“gÌ½Í“hÌ½Í“tÌ½Í“ subjects showed significant blood oxygen lÌ³eÌ³vÌ³eÌ³lÌ³-dependent ğ“»ğ“®ğ“¼ğ“¹ğ“¸ğ“·ğ“¼ğ“®ğ“¼ in the ğ¯ğğ§ğ­ğ«ğ¨ğ¦ğğğ¢ğšğ¥ ğ“¹ğ“»ğ“®ğ“¯ğ“»ğ“¸ğ“·ğ“½ğ“ªğ“µ cortex (ğ”³ğ”ªğ”“ğ”‰â„­) to food aÌ´rÌ´oÌ´mÌ´aÌ´sÌ´ compared ğ°ğ¢ğ­ğ¡ responses induced by the ğ• ğ••ğ• ğ•£ of an inedible object.,3
Female :Ì½Í“ 35.6%.,3
FÍeÍmÍaÍlÍeÍ: 35.6%.,3
ğ—™ğ—²ğ—ºğ—®ğ—¹ğ—²: 35.6%.,3
Female: 3Ì¾5Ì¾.Ì¾6Ì¾%.,3
Female: 35.6%.,3
Female: 35.6%.,3
"PrEP iÌ²sÌ² efficacious for HIV-1 prevention among women ğ“Šğ“ˆğ’¾ğ“ƒğ‘” DMPA and men wÍhÍoÍsÍeÍ partners use DMPA ,Ì´ suggesting PrEP ğ—°ğ—¼ğ˜‚ğ—¹ğ—± mitigate the potential ÉªÉ´á´„Ê€á´‡á´€êœ±á´‡á´… HIV-1 aÌ´cÌ´qÌ´uÌ´iÌ´sÌ´iÌ´tÌ´iÌ´oÌ´nÌ´ and transmission risks that ğ¡ğšğ¯ğ bÌ½Í“eÌ½Í“eÌ½Í“nÌ½Í“ ğ™–ğ™¨ğ™¨ğ™¤ğ™˜ğ™ğ™–ğ™©ğ™šğ™™ with ğ™³ğ™¼ğ™¿ğ™° use.",4
"PrEP ğ”¦ğ”° á´‡êœ°êœ°Éªá´„á´€á´„Éªá´á´œêœ± ğ”£ğ”¬ğ”¯ HÌ³IÌ³VÌ³-1 prevention among women ğ”²ğ”°ğ”¦ğ”«ğ”¤ ğ‘«ğ‘´ğ‘·ğ‘¨ and men whose partners use DMPA, ğ’”ğ’–ğ’ˆğ’ˆğ’†ğ’”ğ’•ğ’Šğ’ğ’ˆ PrEP could mitigate the potential increased HÌ²IÌ²VÌ²-1Ì½Í“ acquisition ğ˜¢ğ˜¯ğ˜¥ transmission risks that have been associated with DMPA use.",4
"PÍrÍEÍPÍ is efficacious for HIV -Ì½Í“ 1 prevention ğ•’ğ•ğ• ğ•Ÿğ•˜ ğ˜„ğ—¼ğ—ºğ—²ğ—» using DMPA and men wÌ²hÌ²oÌ²sÌ²eÌ² partners ğ”²ğ”°ğ”¢ DÌ´MÌ´PÌ´AÌ´, suggesting PÌ¶rÌ¶EÌ¶PÌ¶ could mitigate the potential increased HIV-1 acquisition and transmission risks that have been aÌ´sÌ´sÌ´oÌ´cÌ´iÌ´aÌ´tÌ´eÌ´dÌ´ ğ”´ğ”¦ğ”±ğ”¥ ğ““ğ“œğ“Ÿğ“ ğ“¾ğ“¼ğ“®.",4
"PrEP is ğ˜¦ğ˜§ğ˜§ğ˜ªğ˜¤ğ˜¢ğ˜¤ğ˜ªğ˜°ğ˜¶ğ˜´ for HIV -Ì´ 1 prevention among women using DMPA aÌ¶nÌ¶dÌ¶ men whose pÌ³aÌ³rÌ³tÌ³nÌ³eÌ³rÌ³sÌ³ use DMPA, suggesting PÌ³rÌ³EÌ³PÌ³ cÌ³oÌ³uÌ³lÌ³dÌ³ ğ“¶ğ“²ğ“½ğ“²ğ“°ğ“ªğ“½ğ“® the potential increased ğ™ƒğ™„ğ™‘-1 acquisition and transmission risks ğ”±ğ”¥ğ”ğ”± ğ˜©ğ˜¢ğ˜·ğ˜¦ been ğ’¶ğ“ˆğ“ˆğ‘œğ’¸ğ’¾ğ’¶ğ“‰ğ‘’ğ’¹ with DMPA use.",4
"ğ˜—ğ˜³ğ˜Œğ˜— is efficacious for HIV-1 pÍrÍeÍvÍeÍnÍtÍiÍoÍnÍ among ğ•¨ğ• ğ•ğ•–ğ•Ÿ using DMPA aÌ·nÌ·dÌ· ğ—ºğ—²ğ—» whose partners use ğ˜‹ğ˜”ğ˜—ğ˜ˆ ,Ì¾ suggesting PrEP could mitigate the potential iÌ½Í“nÌ½Í“cÌ½Í“rÌ½Í“eÌ½Í“aÌ½Í“sÌ½Í“eÌ½Í“dÌ½Í“ HIV-1Ì³ acquisition and transmission risks that have ğ“«ğ“®ğ“®ğ“· aÌ³sÌ³sÌ³oÌ³cÌ³iÌ³aÌ³tÌ³eÌ³dÌ³ with DMPA use.",4
"PÌ´rÌ´EÌ´PÌ´ is efficacious for HÌ¶IÌ¶VÌ¶-1 prevention among women ğ•¦ğ•¤ğ•šğ•Ÿğ•˜ DMPA aÌ¶nÌ¶dÌ¶ men whose partners use DÍMÍPÍAÍ, suggesting PrEP cÌ³oÌ³uÌ³lÌ³dÌ³ mitigate the potential iÌ·nÌ·cÌ·rÌ·eÌ·aÌ·sÌ·eÌ·dÌ· HÌ¶IÌ¶VÌ¶-1 ğšğœğªğ®ğ¢ğ¬ğ¢ğ­ğ¢ğ¨ğ§ ğ’¶ğ“ƒğ’¹ transmission risks that have been associated wÌ¾iÌ¾tÌ¾hÌ¾ DMPA use.",4
"The SSM 30 g may be an effective, noninvasive alternative tÌ´oÌ´ health ğšŒğšŠğš›ğš ğ—½ğ—¿ğ—¼ğ˜ƒğ—¶ğ—±ğ—²ğ—¿-administered intravenous, ğ“²ğ“·ğ“½ğ“»ğ“ªğ“¶ğ“¾ğ“¼ğ“¬ğ“¾ğ“µğ“ªğ“», or oral opioids for the ğ™¢ğ™–ğ™£ğ™–ğ™œğ™šğ™¢ğ™šğ™£ğ™© of moderate-ğ™©ğ™¤-severe ğ’‚ğ’„ğ’–ğ’•ğ’† pain.",4
"The ğ‘ºğ‘ºğ‘´ 3Í0Í gÌ³ may be an effective, nÌ´oÌ´nÌ´iÌ´nÌ´vÌ´aÌ´sÌ´iÌ´vÌ´eÌ´ alternative ğ“½ğ“¸ health care ğ’‘ğ’“ğ’ğ’—ğ’Šğ’…ğ’†ğ’“-administered intravenous, intramuscular, or oral opioids for the management of mÌ³oÌ³dÌ³eÌ³rÌ³aÌ³tÌ³eÌ³-to-ğ¬ğğ¯ğğ«ğ acute pain.",4
"The SSM 30 g ğ”ªğ”ğ”¶ be an effective ,Ì² noninvasive ğšğ¥ğ­ğğ«ğ§ğšğ­ğ¢ğ¯ğ to hÌ½Í“eÌ½Í“aÌ½Í“lÌ½Í“tÌ½Í“hÌ½Í“ care provider-administered intravenous ,Ì½Í“ intramuscular, or oral opioids for the management of moderate-to-severe ğšğœğ®ğ­ğ pain.",4
"ğ—§ğ—µğ—² SSM 3Ì½Í“0Ì½Í“ g may be ğ—®ğ—» effective, noninvasive alternative to health care ğ’‘ğ’“ğ’ğ’—ğ’Šğ’…ğ’†ğ’“ -Ì· ğ•’ğ••ğ•ğ•šğ•Ÿğ•šğ•¤ğ•¥ğ•–ğ•£ğ•–ğ•• intravenous, intramuscular, ğ™¤ğ™§ oral oÌ·pÌ·iÌ·oÌ·iÌ·dÌ·sÌ· ğ™›ğ™¤ğ™§ the management of moderate-to-ğ˜´ğ˜¦ğ˜·ğ˜¦ğ˜³ğ˜¦ acute pain.",4
"The SSM 3Ì²0Ì² g mÌ½Í“aÌ½Í“yÌ½Í“ be an effective, noninvasive ğ™–ğ™¡ğ™©ğ™šğ™§ğ™£ğ™–ğ™©ğ™ğ™«ğ™š to ğš‘ğšğšŠğš•ğšğš‘ ğ” ğ”ğ”¯ğ”¢ pÌ´rÌ´oÌ´vÌ´iÌ´dÌ´eÌ´rÌ´-administered iÍnÍtÍrÍaÍvÍeÍnÍoÍuÍsÍ, intramuscular, or oral opioids for the ğ™¢ğ™–ğ™£ğ™–ğ™œğ™šğ™¢ğ™šğ™£ğ™© of moderate-ğ“½ğ“¸-severe acute pain.Ì¾",4
"The SSM 30 g may be an effective ,Í noninvasive aÌ¶lÌ¶tÌ¶eÌ¶rÌ¶nÌ¶aÌ¶tÌ¶iÌ¶vÌ¶eÌ¶ to hÌ·eÌ·aÌ·lÌ·tÌ·hÌ· ğ•”ğ•’ğ•£ğ•– ğ™¥ğ™§ğ™¤ğ™«ğ™ğ™™ğ™šğ™§-aÌ·dÌ·mÌ·iÌ·nÌ·iÌ·sÌ·tÌ·eÌ·rÌ·eÌ·dÌ· intravenous, iÌ·nÌ·tÌ·rÌ·aÌ·mÌ·uÌ·sÌ·cÌ·uÌ·lÌ·aÌ·rÌ·, or oral oÍpÍiÍoÍiÍdÍsÍ êœ°á´Ê€ the management of moderate-ğšğš˜-severe acute pain.",4
